Analytical Data
-
基因名
FLJ22595
- Application
-
别名
ADP ribosylation factor like 14; ADP-ribosylation factor 7; ADP-ribosylation factor-like protein 14; ARF7; ARL14; ARL14_HUMAN; FLJ22595; OTTHUMP00000213879
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N4G2
-
表达区间
1-192aa
-
氨基酸序列
MGSLGSKNPQTKQAQVLLLGLDSAGKSTLLYKLKLAKDITTIPTIGFNVEMIELERNFSLTVWDVGGQEKMRTVWGCYCENTDGLVYVVDSTDKQRLEESQRQFEHILKNEHIKNVPVVLLANKQDMPGALTAEDITRMFKVKKLCSDRNWYVQPCCALTGEGLAQGFRKLTGFVKSHMKSRGDTLAFFKQN
-
分子量
46.86 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ22595, also known as a recombinant protein, has garnered considerable attention in recent years due to its potential applications in various fields including therapeutics and biotechnology. This protein is encoded by a gene that belongs to a family of proteins involved in critical cellular processes such as signal transduction, metabolism, and cellular response to stress. Research indicates that FLJ22595 exhibits unique structural features and functional properties that may contribute to its biological roles. The recombinant production of this protein allows for detailed studies of its interactions with other biomolecules, paving the way for understanding its mechanism of action. Moreover, insights gained from the study of FLJ22595 could lead to the development of novel therapeutic strategies targeting diseases where its expression is significantly altered. Consequently, the investigation of FLJ22595 is pivotal not only for the elucidation of fundamental biological processes but also for the advancement of medical treatments and biotechnology applications. As such, ongoing research seeks to optimize the production and characterization of FLJ22595, with the goal of harnessing its potential for innovative scientific and clinical applications.
